None listed
Conditions
Brief summary
Healthy men who are tested for prostate cancer are usually not informed of the potential harms of the screening process, such as overdiagnosis and overtreatment. The balance of benefits and harms in screening depends on individual risks and values, and prior research suggested men currently appear inadequately informed. This pilot study will use a randomised controlled trial to investigate the use of Community Jury (a “jury” who undergo 2 days of expert information, discussion and reflection) compared with a standard information group to investigate men's knowledge and attitudes towards prostate cancer testing. In additiion the Community Jury will be asked to recommend hypothethical policy issues regarding testing for prostate cancer in healthy men.
Interventions
Community jury (CJ) members interact, question experts and reflect on information. CJ members will convene on Day 1 for expert interaction about the pros and cons of prostate cancer testing. Experts from Urology and Evidence-based Medicine will hold a seminar session (approximately 1 hour each) after which participants will have an opportunity to ask questions before the next expert seminar. Both seminars will occur over a three hour period to allow for questions and answers and a short break. A
Community jury (CJ) members interact, question experts and reflect on information. CJ members will convene on Day 1 for expert interaction about the pros and cons of prostate cancer testing. Experts from Urology and Evidence-based Medicine will hold a seminar session (approximately 1 hour each) after which participants will have an opportunity to ask questions before the next expert seminar. Both seminars will occur over a three hour period to allow for questions and answers and a short break. After both presentations a facilitator will assist the participants to reflect on the “evidence” and consider further questions that will be put to the experts in a panel forum in the afternoon. Overnight, participants will return to their homes to reflect on the information provided. Clarification of any further questions will occur on Day 2. Participants will be asked to form a consensus (majority decision) about whether to undertake prostate cancer screening; however each participant’s decision will be recorded for data collection. Participants will be requested to complete the post-assessment questionnaire after deliberations on Day 2.
Sponsors
Bond University
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Educational / counselling / training
Masking
Open (masking not used)
Eligibility
Sex/Gender
Male
Age
50 Years to 70 Years
Healthy volunteers
Yes
Inclusion criteria
Male
Exclusion criteria
Previous diagnosis of prostate cancer
Outcome results
None listed